Objective-To test the hypothesis that changes in serum matrix metalloproteinase-1 (MMP-1) and tissue inhibitors of metalloproteinase-1 (TIMP-1) after acute myocardial infarction reflect extracellular matrix remodelling and the infarct healing process. Patients-13 consecutive patients with their first acute myocardial infarction who underwent successful reperfusion. Methods-Blood was sampled on the day of admission, and on days 2, 3, 4, 5, 7, 14, and 28. Serum MMP-1 and TIMP-1 were measured by one step sandwich enzyme inimunoassay. Left ventricular volume indices were determined by left ventriculography performed four weeks after the infarct. Results-Serum concentrations of both MMP-1 and TIMP-1 changed over time. The average serum MMP-1 was more than 1 SD below the mean control values during the initial four days, increased thereafter, reaching a peak concentration around day 14, and then returned to the middle control range. Negative correlations with left ventricular end systolic volume index and positive correlations with left ventricular ejection fraction were obtained for serum MMP-1 on day 5, when it began to rise, and for the magnitude ofrise in MMP-1 on day 5 compared to admission. Serum TIMP-1 at admission was more than 1 SD below the mean control value, and increased gradually thereafter, reaching a peak on around day 14. Negative correlations with left ventricular end systolic volume index and positive correlations with left ventricular ejection fraction were obtained for serum TIMP-1 on days 5 and 7, and for the magnitude ofrise in TIMP-l on days 5 and 7 compared to admission. Conclusions-Both MMP-1 and TIMP-1 showed significant time dependent alteration after acute myocardial infarction. Thus MMP-1 and TIMP-1 may provide useful information in evaluating the healing process as it affects left ventricular remodelling after acute myocardial infarction. (Heart 1997;78:278-284) Keywords: left ventriculography; ventricular remodelling; matrix metalloproteinase-1; tissue inhibitor of metalloproteinase-1; fibrosis Left ventricular volume is one of the major prognostic factors after acute myocardial infarction.' 2 Ventricular remodelling is thus important with respect to prognosis.34 The extracellular matrix plays a vital role not only in the maintenance of ventricular shape but also in ventricular function. Collagen is apparently an essential component of the extracellular matrix, and collagenases and their inhibitors play crucial roles in extracellular matrix homeostasis.5 Recent biological studies have identified several distinct matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) and have delineated their characteristics.56 The important roles of MMP and TIMP in cardiovascular disease have been reviewed by Dollery et al.7 MMP-1, a 54 kDa interstitial collagenase, degrades several types of collagen and other extracellular matrix components, including types I and III collagen, the major types of collagen in the collagen matrix.57 TIMP-1, a 29 5 kDa sialoglycoprotein, forms a complex with MMP-189 and acts as a native inhibitor of MMP-1. Inhibitory regulation of MMP-1 activity is mediated in part by TIMP-1. MMP-1 and TIMP-1 thus contribute bidirectionally to the control of collagen matrix maintenance. During extracellular matrix remodelling, degradation and reformation of extracellular matrix occur, and both MMP and TIMP contribute to this process through the balance of their activities. We hypothesised that changes in serum MMP and TIMP concentrations reflect the extracellular matrix remodelling involved in the infarct healing process and that these changes would thus be correlated with left ventricular volume indices. Although there are reports of increased expression of TIMP in chronic liver disease'0 and rheumatoid arthritis," there are none on changes in serum MMP and TIMP after acute myocardial infarction. We therefore examined the relations of serum MMP-1 and TIMP-1 to left ventricular volume indices obtained by left ventriculography in patients after myocardial infarction.
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Methods

PATIENTS
To determine the sequential changes in serum MMP-1 and TIMP-1 from the infarct onset day, we studied 13 consecutive patients with their first acute myocardial infarct who were admitted within 12 '5 The detection limit of this MMP-1 assay system is 1 0 ng/ml, and linearity is determined from 1 to 64 ng/ml. The intraassay and interassay coefficients of variation were 2-0-4-3% and < 5%, respectively.
Serum TIMP-1 concentration was also measured by a one step sandwich enzyme immunoassay kit (Fuji Chemical Industries, Takaoka, Japan) using a monoclonal antibody purified from bovine dental pulp TIMP which cross reacts with human TIMP-1. 16 1 The immunoassay system for TIMP-1 reacts almost equally with free TIMP-1 and with TIMP-1 complexed with MMP-1, -2, -3, and 9.16 The detection limit of this TIMP-1 assay system is 1 2 ng/ml, and linearity is determined from 51 to 2000 ng/ml. The intra-assay and interassay coefficients of variation were 1-9-4-5% and 2-8-4-3 %, respectively. The control range for MMP-1 and TIMP-1 was obtained from 18 age and gender matched healthy volunteers aged 62 (SD 7) years (nine men and nine women). The ranges within 1 SD of the mean of the controls for MMP-1 and TIMP-1 and the means (SD) were 3T2-34-5 ng/ml (13-1 (9-3) ng/ml) and 109-177 ng/ml (139 (20) 0 10 > P > 0 05). Similarly, the serum concentrations on day 5 and the magnitude of serum concentration changes on day 5 compared to those on admission were both correlated with wall motion score (r = -0-68, P < 0 05 and r = -0 73, P < 0 01, respectively). 
Time course
The sequential changes in TIMP-1 after acute myocardial infarction in the 13 patients are shown in fig 3. The time from onset of acute myocardial infarction to blood sampling was not correlated with serum TIMP-1 on admission. As with MMP-1, mean serum TIMP-1 at admission was more than 1 SD below the mean control value. It then increased and reached a maximum at around day 14, subsequently decreasing to within the normal range for controls. ANOVA again showed that this change was significant (P < 0 01).
Relations to left ventricular indices
As with MMP-1, serum TIMP-1 values on day 5 and day 7 were negatively correlated with left ventricular end systolic volume index (r = -0O76, P < 0-01, and r = -0O58, P < 0 05, respectively), and positively correlated with the left ventricular ejection fraction (r = 0-84, P < 0-01, and r = 0 79, P < 005, respectively) (fig 4) . The magnitude of the rise in serum TIMP-1 on day 5 and day 7 was negatively correlated with the left ventricular end systolic volume index (r = -0-78, P < 0 01, and r = -0-62, P < 005, respectively) and positively correlated with the left ventricular ejection fraction (r = 079, P < 0.01, and r = 0-63, P < 0.05, respectively). Neither the values on the averaged peak day (day 14) nor those on the individual peak days were correlated with any of the indices.
Relation to regional wall motion Serum TIMP-1 values on day 5 and day 7 were correlated with percentage area less than -2 SD/chord (r = -0-84, P < 0 01, and r = -0-65, P < 0-05, respectively) (fig 4) . The magnitude of the change of the serum concentrations on the respective days compared to those on admission were also correlated with the area (r = -0-83, P < 0 01, and r = -066, P < 0-05, respectively). Similarly, the serum concentrations on day 5 and day 7 were correlated with wall motion score (r = -092, P < 0*01, and r = -0-66, P < 0 05, respectively).
The magnitude of the serum concentration changes on day 5 and day 7 with respect to the admission values was correlated with the wall motion score (r = -0*91, P < 0*01, and r = -0-68, P < 0-05, respectively).
Relation to CK release Neither the serum TIMP-1 on day 5 nor the magnitude of serum concentration changes on day 5 compared to the admission values was significantly correlated with the CK release or with the duration from onset to CKmax. Discussion This study showed that the serum concentrations of both MMP-1 and TIMP-1 changed significantly and time dependently from low concentrations, below the control range, to above the control range after acute myocardial infarction. At the time when serum MMP-1 began to rise from its initially low value, serum concentrations of both MMP-1 and TIMP-1 were negatively correlated with the left ventricular end systolic volume index and positively correlated with the left ventricular ejection fraction. There were similar relations between the rise in MMP-1 and TIMP-1 concentrations from their admission values and the left ventricular end systolic volume index and ejection fraction.
The methods we used for determining serum MMP-1 and TIMP-1 are well established,'5-'7 and the intra-assay and interassay coefficients of variation are sufficiently small. Left ventriculography was performed in a single projection (the right anterior oblique view). Greene et al 18 reported a good correlation between the left ventricular volumes measured using single plane and biplane methods. Moreover, we carefully selected only patients with lesions located in the left anterior descending coronary artery or the right coronary artery territory. These considerations suggest that the methods we used are valid.
The concentrations of MMP-1 on days 1 to 4 and of TIMP-1 on the admission day were more than 1 SD below the mean for the control value. Both MMP-1 and TIMP-1 are tightly controlled by a variety of mechanisms and play important roles in extracellular matrix degradation and remodelling. Although our study did not provide any evidence relating to the mechanism by which the serum concentrations are affected in acute myocardial infarction, the low values might be explained by one or more of three mechanisms: (1) reduced synthesis, (2) increased turnover of serum MMP-1 and TIMP-1, and (3) changes in equilibrium between serum and tissue concentrations, that is, reduced release from tissue or mobilisation from serum to tissue.
REDUCED SYNTHESIS
Regarding synthesis of MMP-1, Cleutjens et al24 showed increased MMP-1 activity in infarct tissue by zymography, followed by increments of MMP-1 mRNA, in experimental infarction in rats. Tumour necrosis factor a (TNFa) and interleukin-1 (IL-1) are known to be potent stimulators of MMP-1 at transcriptional level.'5 It was also suggested that an increase in circulating cytokines contributes to raised MMP-3 concentrations in patients with rheumatoid arthritis. 26 Herskowitz et a"27 examined proinflammatory cytokines in the infarct by northern blotting after reperfusion following acute myocardial infarction in rats, and showed that TNFa mRNA and IL-1p mRNA in the infarct tissue both increased, with two peaks-1 to 2 hours after reperfusion and on day 7. Increased serum TNFa concentrations, measured by enzyme linked immunoabsorbent assay, have also been found in the early phase of human acute myocardial infarction. '8 This reported evidence about the influence of cytokines on MMP suggests that the synthesis of MMP is enhanced rather than depressed. Further, increased concentrations of tissue plasminogen activator, which converts plasminogen to plasmin, have been found in the acute phase by the double antibody sandwich method,29 and plasmin is also known to activate MMP. 7 Coexpression of MMP and TIMP has been shown in the myocardium30 and human burn wounds,3' indicating that extracellular matrix degradation and reformation are regulated through the balance of concomitant expression of MMP and TIMP. These lines of evidence indicate that synthesis or activation of MMP-1 and TIMP-1 is more likely to be enhanced than reduced in the early phase of acute myocardial infarction.
TURNOVER
With respect to serum turnover of MMP-1 and TIMP-1, activated collagenase can be disrupted by a, macroglobulin32 33 or acute inflammatory reactant, and it is possible that these substances reduced the serum concentrations of MMP-1 and/or TIMP-1. However, in this study no significant correlation was obtained between either serum C reactive protein or neutrophil counts and the serum concentrations of MMP-1 and TIMP-1 on the day of admission or day 5. a, Macroglobulin has been shown not to interfere with the measurements of MMP-1 in the present assay system.'5 Furthermore, the serum a, macroglobulin concentrations do not differ in patients with acute myocardial infarction and controls. 29 Although we found no reported data on the serum half life of MMP-1 and TIMP-1 in acute myocardial infarction and were unable to provide data on this from our study, we do not believe that acute inflammatory reactants and a, macroglobulin could account for the low initial serum concentrations of MMP-1 and TIMP-1.
CHANGES IN EQUILIBRIUM BETWEEN SERUM AND TISSUE
Mobilisation of MMP-1 and TIMP-1 from the blood stream to the infarct tissue or their decreased release into to the blood stream from the tissues might explain the initial low levels, though this explanation is entirely speculative. Tyagi et al30 showed that MMP are present in the endothelium and subendothelial space of the endocardium and throughout the interstitial spaces of rat hearts. Cleutjens et al 24 examined MMP-1 and TIMP-1 by zymography, northern blotting, and in situ hybridisation in experimental myocardial infarction in rats and postulated activation of latent MMP-1 pooled in the interstitial spaces as the initial process, and synthesis of collagenase mRNA when pooled MMP is reduced. These findings suggest that the release of MMP into serum would be reduced. They also showed that TIMP mRNA increased six hours after coronary ligation and reached a maximum level on day 2, remaining high by day 7. These experi-mental results and our observation of initially low serum concentrations of both MMP-1 and TIMP-1 lead us to speculate that activation of pooled latent MMP-1 is the initial process, but that the production of MMP-1 and TIMP-1 does not exceed their local consumption. Mobilisation from the blood stream to the interstitial spaces or reduction in release from myocardial tissue to the serum seem to be the most likely explanations for their low initial serum concentrations.
The concentrations of both MMP-1 and TIMP-1 at the time when MMP-1 began to increase into the control range were correlated with the left ventricular end systolic volume index and ejection fraction, and with the regional wall motion of the infarct, but the average peak day (day 14) concentrations or the individual peak concentrations were not correlated with any of the left ventricular indices. This suggests that the serum values of both MMP-1 and TIMP-1 reflect the healing stages of the infarct rather than the precise activity of infarct fibrogenesis. Thus, prolonged healing of the infarct might be reflected in delayed return of these serum values, resulting in low values at the time when the MMP-1 was beginning to return to the control range, whereas faster healing might be reflected in a faster return, resulting in relatively high normal range values on that day. This could explain the relation of their sequential changes to left ventricular indices, although we emphasise that this is entirely speculative.
It is well known that healing speed is correlated with infarct size. Although we found no significant correlation of serum concentrations of MMP-1 or TIMP-1 on day 5 with integral CK release, and the serum MMP-1 concentrations on day 5 showed a weak non-significant relation to the integral CK release, the values were correlated with percentage area less than -2 SD/chord, which indicates infarct area. 19 Integral CK release indicates loss of myocytes, whereas it is theoretically reasonable to suppose that MMP-1 and TIMP-1 act in response to extracellular matrix damage caused by the infarct. It can also be surmised that the extracellular matrix structure differs from patient to patient with respect to the number of myocytes. This would at least partly account for the lack of a direct correlation between the integral CK release and sequential changes of MMP-1 and TIMP-1.
Extracellular matrix degradation and reformation is regulated through the balance between MMP and TIMP. We cannot comment on this in detail because the immunoassay we used detects not only proMMP-1 and active MMP-1 but also MMP-1 complexed to TIMP-1, and conversely the TIMP-1 assay system detects TIMP-1 together with TIMP-1 complexed with MMPs.
LIMITATIONS OF THE STUDY
This study has several apparent limitations. First, because of careful selection, a relatively small number of patients was included. Second, the assay system used in this study for MMP-1 could not distinguish active MMP-1 from proMMP-1 or from MMP-1 complexed with TIMPs. Similarly, the assay system for TIMP-1 could not distinguish free TIMP-1 from TIMP-1 conjugated with MMPs. The present assay method detected almost all MMP-1 and TIMP-1. Thus this study could not provide further information on various forms of MMP-1 and TIMP-1.
CONCLUSION
Our study demonstrated sequential changes in the serum MMP-1 and TIMP-1 concentrations after acute myocardial infarction, and indicated that the measurement of these enzymes may provide useful information on left ventricular remodelling.
